| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |